HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection

Journal: Journal of Experimental Medicine

Published: 2020-07-06

DOI: 10.1084/jem.20191422

Affiliations: 13

Authors: 16

Institutions	Authors	Share
Department of Biomedicine, AU, Denmark		0.27
Department of Psychiatry and Neurochemistry, GU, Sweden		0.14
LICR Oxford Branch, United Kingdom (UK)		0.09
Department of Rheumatology and Inflammation Research, GU, Sweden		0.09
Institute of Virology, MHH, Germany		0.09
Cluster of Excellence - Resolving Infection Susceptibility (RESIST), MHH, Germany		0.09
University of Kansas Medical Center (KUMC), United States of America (USA)		0.06
Faculty of Medicine, ICL, United Kingdom (UK)		0.06
Department of Clinical Medicine, AU, Denmark		0.02
Department of Infectious Diseases, AU, Denmark		0.02
Sahlgrenska University Hospital (SU), GU, Sweden		0.02
UK DRI at Imperial College London (UK DRI ICL), United Kingdom (UK)		0.02
UCL Department of Neurodegenerative Disease, United Kingdom (UK)		0.02

Return

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free